Skip to Main Content

Filter:

Editorials

1 Results

Editorial
Understanding Heart Failure Risk in a Diverse Cohort With Human Immunodeficiency Virus Infection
Mayo Clinic Proceedings
Vol. 97Issue 3p433–435Published in issue: March, 2022
- Christian Faaborg-Andersen
- Adrian daSilva-deAbreu
- Hector O. Ventura
Cited in Scopus: 0
After 4 decades of study and numerous therapeutic advancements, human immunodeficiency virus (HIV) infection can today be considered and managed as a chronic disease, and in some parts of the world, the life expectancy of persons living with HIV (PWHs) is comparable to that of persons living without such infection.¹ Since it was discovered in the early 1980s, HIV has been known to affect the heart. As PWHs are living longer, their burden of cardiovascular disease (CVD) and their clinical relevance have grown, raising important questions about the pathophysiologic process through which the HIV affects the heart despite optimal treatment with antiretroviral therapy (ART).